These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7273255)

  • 1. Identification of a reactive metabolite of the mutagen, 2-amino-3-methylimidazolo[4,5-f]quinoline.
    Okamoto T; Shudo K; Hashimoto Y; Kosuge T; Sugimura T; Nishimura S
    Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):590-3. PubMed ID: 7273255
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenicity and in vitro covalent DNA binding of 2-hydroxyamino-3-methylimidazolo[4,5-f]quinoline.
    Snyderwine EG; Wirth PJ; Roller PP; Adamson RH; Sato S; Thorgeirsson SS
    Carcinogenesis; 1988 Mar; 9(3):411-8. PubMed ID: 3162208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the metabolism of mutagens occurring in food by arachidonic acid.
    Ho TA; Coutts TM; Rowland IR; Alldrick AJ
    Mutat Res; 1992 Oct; 269(2):279-84. PubMed ID: 1383712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes.
    Kaderlik KR; Mulder GJ; Turesky RJ; Lang NP; Teitel CH; Chiarelli MP; Kadlubar FF
    Carcinogenesis; 1994 Aug; 15(8):1695-701. PubMed ID: 8055651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of pyrolysate arylamines by human liver microsomes; possible involvement of a P-488-H type cytochrome P-450.
    Yamazoe Y; Abu-Zeid M; Yamauchi K; Kato R
    Jpn J Cancer Res; 1988 Nov; 79(11):1159-67. PubMed ID: 3147272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotoxic activity of the N-acetylated metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ).
    Brunborg G; Holme JA; Alexander J; Becher G; Hongslo JK
    Mutagenesis; 1988 Jul; 3(4):303-9. PubMed ID: 3062317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences.
    Abu-Shakra A; Ioannides C; Walker R
    Mutagenesis; 1986 Sep; 1(5):367-70. PubMed ID: 3331675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatic conversion of some heterocyclic amines to bacterial mutagens is modified by dietary fat and cholesterol.
    Alldrick AJ; Rowland IR; Wise A
    Mutagenesis; 1987 May; 2(3):221-4. PubMed ID: 3325747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin H synthase-dependent formation of the direct-acting mutagen 2-nitro-3-methylimidazo[4,5-f]quinoline (nitro-IQ) from IQ.
    Morrison LD; Eling TE; Josephy PD
    Mutat Res; 1993 May; 302(1):45-52. PubMed ID: 7683106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of mutagenicity-deprived 3-fluoroquinoline: comparison with mutagenic quinoline.
    Saeki K; Takahashi K; Kawazoe Y
    Biol Pharm Bull; 1993 Mar; 16(3):232-4. PubMed ID: 8364465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the metabolites of benzo[f]quinoline and benzo[h]quinoline formed by rat liver homogenate.
    LaVoie EJ; Adams EA; Hoffmann D
    Carcinogenesis; 1983 Sep; 4(9):1133-8. PubMed ID: 6883636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsomal activation of 2-amino-3-methylimidazo[4,5-f]quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate.
    Yamazoe Y; Shimada M; Kamataki T; Kato R
    Cancer Res; 1983 Dec; 43(12 Pt 1):5768-74. PubMed ID: 6416669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-(2-amino-1-methylimidazo[4,5-b]pyrid-6-yl)phenyl sulfate--a major metabolite of the food mutagen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) in the rat.
    Alexander J; Wallin H; Holme JA; Becher G
    Carcinogenesis; 1989 Aug; 10(8):1543-7. PubMed ID: 2752529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of anthraquinones as inhibitors of 7-ethoxycoumarin O-deethylase and mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline.
    Hao NJ; Huang MP; Lee H
    Mutat Res; 1995 May; 328(2):183-91. PubMed ID: 7739602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the food mutagens IQ and MeIQ by hepatic S9 fractions derived from various species.
    Alldrick AJ; Rowland IR
    Mutat Res; 1985 Oct; 144(2):59-62. PubMed ID: 3900706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro DNA binding of 2-amino-3-methylimidazo(4,5-f)[5-3H]quinoline (IQ) is modulated by sulfotransferase and sulfate levels.
    Lodovici M; Grassi M; Dolara P
    Mutat Res; 1989 Jul; 223(3):321-4. PubMed ID: 2739687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the antimutagenic potential of anthracene: in vitro and ex vivo studies.
    Bu-Abbas A; Ioannides C; Walker R
    Mutat Res; 1994 Aug; 309(1):101-7. PubMed ID: 7519726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of a base in DNA modified by Glu-P-1.
    Hashimoto Y; Shudo K; Okamoto T
    Chem Pharm Bull (Tokyo); 1979 Oct; 27(10):2532-4. PubMed ID: 527139
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of the food derived mutagen and carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) by human liver microsomes.
    Zhao K; Murray S; Davies DS; Boobis AR; Gooderham NJ
    Carcinogenesis; 1994 Jun; 15(6):1285-8. PubMed ID: 8020169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, purification and mutagenicity of 2-hydroxyamino-3-methylimidazolo[4,5-f]quinoline.
    Snyderwine EG; Roller PP; Wirth PJ; Adamson RH; Sato S; Thorgeirsson SS
    Carcinogenesis; 1987 Jul; 8(7):1017-20. PubMed ID: 3594719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.